Newborn Screening Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type (Dry Blood Spot Test, CCHD), By Region - Industry Forecast 2024-2031

Asia Pacific had the highest share of 32.90% in the newborn screening market. This leadership is due to new growth prospects along with better healthcare services and infrastructure. The demand for newborn screening techniques is a result of a high birth rate, dense population, and rising incidence of congenital disorders in the region. Government programs and spending on healthcare facilities are forecast to push the market further. The Asia Pacific is expected to grow at the fastest rate, followed by countries such as China and India that are setting benchmarks for advanced newborn screening techniques.

The increasing birth defect prevalence and widespread screening in each state across the union are expected to drive the growth in North America at an extra-ordinary compounded annual growth rate (CAGR) in the next years. Every newborn is screened for birth defects through universal screening programs such as the Texas Newborn Screening Program, the California Newborn Screening Program, and the New York State Newborn Screening Program. This enforcement goes along with the advanced health care system and high parental awareness. Hence, this has resulted in a substantial market share in the region. North America is expected to gain more market share in the newborn screening market due to continued R&D in newborn screening technologies.